nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR1—Alzheimer's disease	0.519	1	CbGaD
Fulvestrant—CYP3A4—Rivastigmine—Alzheimer's disease	0.0677	0.432	CbGbCtD
Fulvestrant—CYP3A4—Donepezil—Alzheimer's disease	0.0542	0.345	CbGbCtD
Fulvestrant—CYP3A4—Galantamine—Alzheimer's disease	0.0349	0.223	CbGbCtD
Fulvestrant—Embolism venous—Memantine—Alzheimer's disease	0.003	0.0173	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00228	0.0131	CcSEcCtD
Fulvestrant—Bone pain—Galantamine—Alzheimer's disease	0.00225	0.013	CcSEcCtD
Fulvestrant—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00205	0.0118	CcSEcCtD
Fulvestrant—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.002	0.0115	CcSEcCtD
Fulvestrant—Vasodilation procedure—Donepezil—Alzheimer's disease	0.0019	0.0109	CcSEcCtD
Fulvestrant—Vasodilation—Donepezil—Alzheimer's disease	0.0019	0.0109	CcSEcCtD
Fulvestrant—Accidental injury—Donepezil—Alzheimer's disease	0.00189	0.0109	CcSEcCtD
Fulvestrant—ESR1—blood vessel—Alzheimer's disease	0.00188	0.0918	CbGeAlD
Fulvestrant—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00184	0.0106	CcSEcCtD
Fulvestrant—Cough increased—Donepezil—Alzheimer's disease	0.00182	0.0105	CcSEcCtD
Fulvestrant—Accidental injury—Memantine—Alzheimer's disease	0.00171	0.00987	CcSEcCtD
Fulvestrant—Injury—Galantamine—Alzheimer's disease	0.0017	0.0098	CcSEcCtD
Fulvestrant—Arthritis—Galantamine—Alzheimer's disease	0.00161	0.00927	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.0016	0.00923	CcSEcCtD
Fulvestrant—Bone pain—Memantine—Alzheimer's disease	0.00158	0.00912	CcSEcCtD
Fulvestrant—Pain in extremity—Galantamine—Alzheimer's disease	0.00156	0.00901	CcSEcCtD
Fulvestrant—Bone pain—Rivastigmine—Alzheimer's disease	0.00155	0.00892	CcSEcCtD
Fulvestrant—Inflammation—Rivastigmine—Alzheimer's disease	0.00153	0.00881	CcSEcCtD
Fulvestrant—ESR2—forebrain—Alzheimer's disease	0.00145	0.0707	CbGeAlD
Fulvestrant—EPHX2—cerebellum—Alzheimer's disease	0.00141	0.0687	CbGeAlD
Fulvestrant—ESR2—telencephalon—Alzheimer's disease	0.00133	0.065	CbGeAlD
Fulvestrant—Injury—Donepezil—Alzheimer's disease	0.00132	0.0076	CcSEcCtD
Fulvestrant—ESRRA—nervous system—Alzheimer's disease	0.00131	0.0639	CbGeAlD
Fulvestrant—Hot flush—Donepezil—Alzheimer's disease	0.00129	0.00746	CcSEcCtD
Fulvestrant—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00128	0.0074	CcSEcCtD
Fulvestrant—ESRRA—central nervous system—Alzheimer's disease	0.00126	0.0616	CbGeAlD
Fulvestrant—Arthritis—Donepezil—Alzheimer's disease	0.00125	0.00718	CcSEcCtD
Fulvestrant—ESRRA—cerebellum—Alzheimer's disease	0.00123	0.0602	CbGeAlD
Fulvestrant—Hepatic failure—Memantine—Alzheimer's disease	0.00122	0.00705	CcSEcCtD
Fulvestrant—Depression—Galantamine—Alzheimer's disease	0.0012	0.00692	CcSEcCtD
Fulvestrant—Injury—Memantine—Alzheimer's disease	0.0012	0.0069	CcSEcCtD
Fulvestrant—Hot flush—Memantine—Alzheimer's disease	0.00118	0.00678	CcSEcCtD
Fulvestrant—Urinary tract infection—Galantamine—Alzheimer's disease	0.00117	0.00675	CcSEcCtD
Fulvestrant—Injury—Rivastigmine—Alzheimer's disease	0.00117	0.00675	CcSEcCtD
Fulvestrant—Menopausal symptoms—Memantine—Alzheimer's disease	0.00117	0.00672	CcSEcCtD
Fulvestrant—Hot flush—Rivastigmine—Alzheimer's disease	0.00115	0.00663	CcSEcCtD
Fulvestrant—EPHX2—brain—Alzheimer's disease	0.00114	0.0558	CbGeAlD
Fulvestrant—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00114	0.00657	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00114	0.00657	CcSEcCtD
Fulvestrant—Arthritis—Memantine—Alzheimer's disease	0.00113	0.00652	CcSEcCtD
Fulvestrant—ESR1—embryo—Alzheimer's disease	0.00112	0.0547	CbGeAlD
Fulvestrant—Arthritis—Rivastigmine—Alzheimer's disease	0.00111	0.00638	CcSEcCtD
Fulvestrant—Pain in extremity—Memantine—Alzheimer's disease	0.0011	0.00634	CcSEcCtD
Fulvestrant—Haemoglobin—Galantamine—Alzheimer's disease	0.00109	0.00626	CcSEcCtD
Fulvestrant—Hepatitis—Galantamine—Alzheimer's disease	0.00108	0.00623	CcSEcCtD
Fulvestrant—Haemorrhage—Galantamine—Alzheimer's disease	0.00108	0.00623	CcSEcCtD
Fulvestrant—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00108	0.0062	CcSEcCtD
Fulvestrant—Oedema peripheral—Galantamine—Alzheimer's disease	0.00107	0.00614	CcSEcCtD
Fulvestrant—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00106	0.00613	CcSEcCtD
Fulvestrant—Influenza—Donepezil—Alzheimer's disease	0.00105	0.00603	CcSEcCtD
Fulvestrant—ESRRA—brain—Alzheimer's disease	0.001	0.0489	CbGeAlD
Fulvestrant—ESR1—forebrain—Alzheimer's disease	0.000992	0.0484	CbGeAlD
Fulvestrant—Angiopathy—Galantamine—Alzheimer's disease	0.000981	0.00566	CcSEcCtD
Fulvestrant—Immune system disorder—Galantamine—Alzheimer's disease	0.000977	0.00563	CcSEcCtD
Fulvestrant—Breast disorder—Rivastigmine—Alzheimer's disease	0.000972	0.0056	CcSEcCtD
Fulvestrant—Influenza—Memantine—Alzheimer's disease	0.000951	0.00548	CcSEcCtD
Fulvestrant—Malnutrition—Galantamine—Alzheimer's disease	0.000941	0.00543	CcSEcCtD
Fulvestrant—Infestation—Donepezil—Alzheimer's disease	0.000933	0.00538	CcSEcCtD
Fulvestrant—Infestation NOS—Donepezil—Alzheimer's disease	0.000933	0.00538	CcSEcCtD
Fulvestrant—Depression—Donepezil—Alzheimer's disease	0.000931	0.00537	CcSEcCtD
Fulvestrant—ESR1—telencephalon—Alzheimer's disease	0.000912	0.0445	CbGeAlD
Fulvestrant—Back pain—Galantamine—Alzheimer's disease	0.00091	0.00525	CcSEcCtD
Fulvestrant—Urinary tract infection—Donepezil—Alzheimer's disease	0.000907	0.00523	CcSEcCtD
Fulvestrant—Sweating—Donepezil—Alzheimer's disease	0.000895	0.00516	CcSEcCtD
Fulvestrant—Anaemia—Galantamine—Alzheimer's disease	0.00087	0.00502	CcSEcCtD
Fulvestrant—Infestation NOS—Memantine—Alzheimer's disease	0.000848	0.00489	CcSEcCtD
Fulvestrant—Infestation—Memantine—Alzheimer's disease	0.000848	0.00489	CcSEcCtD
Fulvestrant—Vertigo—Galantamine—Alzheimer's disease	0.000846	0.00487	CcSEcCtD
Fulvestrant—Depression—Memantine—Alzheimer's disease	0.000845	0.00487	CcSEcCtD
Fulvestrant—Haemoglobin—Donepezil—Alzheimer's disease	0.000842	0.00486	CcSEcCtD
Fulvestrant—Haemorrhage—Donepezil—Alzheimer's disease	0.000838	0.00483	CcSEcCtD
Fulvestrant—Hepatitis—Donepezil—Alzheimer's disease	0.000838	0.00483	CcSEcCtD
Fulvestrant—Pharyngitis—Donepezil—Alzheimer's disease	0.000832	0.00479	CcSEcCtD
Fulvestrant—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000829	0.00478	CcSEcCtD
Fulvestrant—Infestation—Rivastigmine—Alzheimer's disease	0.000829	0.00478	CcSEcCtD
Fulvestrant—Depression—Rivastigmine—Alzheimer's disease	0.000827	0.00477	CcSEcCtD
Fulvestrant—Oedema peripheral—Donepezil—Alzheimer's disease	0.000825	0.00476	CcSEcCtD
Fulvestrant—Urinary tract infection—Memantine—Alzheimer's disease	0.000824	0.00475	CcSEcCtD
Fulvestrant—Cough—Galantamine—Alzheimer's disease	0.000821	0.00473	CcSEcCtD
Fulvestrant—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000806	0.00465	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000802	0.00462	CcSEcCtD
Fulvestrant—Myalgia—Galantamine—Alzheimer's disease	0.000801	0.00462	CcSEcCtD
Fulvestrant—Arthralgia—Galantamine—Alzheimer's disease	0.000801	0.00462	CcSEcCtD
Fulvestrant—Chest pain—Galantamine—Alzheimer's disease	0.000801	0.00462	CcSEcCtD
Fulvestrant—Anxiety—Galantamine—Alzheimer's disease	0.000799	0.0046	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000796	0.00459	CcSEcCtD
Fulvestrant—Sweating—Rivastigmine—Alzheimer's disease	0.000795	0.00458	CcSEcCtD
Fulvestrant—ESR2—nervous system—Alzheimer's disease	0.000786	0.0384	CbGeAlD
Fulvestrant—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000784	0.00452	CcSEcCtD
Fulvestrant—Haemoglobin—Memantine—Alzheimer's disease	0.000765	0.00441	CcSEcCtD
Fulvestrant—Hepatitis—Memantine—Alzheimer's disease	0.000761	0.00439	CcSEcCtD
Fulvestrant—Haemorrhage—Memantine—Alzheimer's disease	0.000761	0.00439	CcSEcCtD
Fulvestrant—ESR2—central nervous system—Alzheimer's disease	0.000757	0.0369	CbGeAlD
Fulvestrant—Pharyngitis—Memantine—Alzheimer's disease	0.000755	0.00435	CcSEcCtD
Fulvestrant—Nervous system disorder—Galantamine—Alzheimer's disease	0.000753	0.00434	CcSEcCtD
Fulvestrant—Oedema peripheral—Memantine—Alzheimer's disease	0.00075	0.00432	CcSEcCtD
Fulvestrant—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000748	0.00431	CcSEcCtD
Fulvestrant—Connective tissue disorder—Memantine—Alzheimer's disease	0.000748	0.00431	CcSEcCtD
Fulvestrant—Skin disorder—Galantamine—Alzheimer's disease	0.000746	0.0043	CcSEcCtD
Fulvestrant—Hepatitis—Rivastigmine—Alzheimer's disease	0.000744	0.00429	CcSEcCtD
Fulvestrant—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000744	0.00429	CcSEcCtD
Fulvestrant—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000743	0.00428	CcSEcCtD
Fulvestrant—ESR2—cerebellum—Alzheimer's disease	0.00074	0.0361	CbGeAlD
Fulvestrant—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000739	0.00426	CcSEcCtD
Fulvestrant—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000733	0.00423	CcSEcCtD
Fulvestrant—Anorexia—Galantamine—Alzheimer's disease	0.000732	0.00422	CcSEcCtD
Fulvestrant—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000731	0.00422	CcSEcCtD
Fulvestrant—Malnutrition—Donepezil—Alzheimer's disease	0.000729	0.00421	CcSEcCtD
Fulvestrant—Back pain—Donepezil—Alzheimer's disease	0.000706	0.00407	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0007	0.00403	CcSEcCtD
Fulvestrant—Insomnia—Galantamine—Alzheimer's disease	0.000695	0.00401	CcSEcCtD
Fulvestrant—Angiopathy—Memantine—Alzheimer's disease	0.00069	0.00398	CcSEcCtD
Fulvestrant—Paraesthesia—Galantamine—Alzheimer's disease	0.00069	0.00398	CcSEcCtD
Fulvestrant—Immune system disorder—Memantine—Alzheimer's disease	0.000687	0.00396	CcSEcCtD
Fulvestrant—Dyspepsia—Galantamine—Alzheimer's disease	0.000676	0.0039	CcSEcCtD
Fulvestrant—Angiopathy—Rivastigmine—Alzheimer's disease	0.000675	0.00389	CcSEcCtD
Fulvestrant—Anaemia—Donepezil—Alzheimer's disease	0.000674	0.00389	CcSEcCtD
Fulvestrant—Decreased appetite—Galantamine—Alzheimer's disease	0.000668	0.00385	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000663	0.00382	CcSEcCtD
Fulvestrant—Malnutrition—Memantine—Alzheimer's disease	0.000662	0.00382	CcSEcCtD
Fulvestrant—Fatigue—Galantamine—Alzheimer's disease	0.000662	0.00382	CcSEcCtD
Fulvestrant—Constipation—Galantamine—Alzheimer's disease	0.000657	0.00379	CcSEcCtD
Fulvestrant—Vertigo—Donepezil—Alzheimer's disease	0.000655	0.00378	CcSEcCtD
Fulvestrant—Malnutrition—Rivastigmine—Alzheimer's disease	0.000648	0.00374	CcSEcCtD
Fulvestrant—Back pain—Memantine—Alzheimer's disease	0.000641	0.00369	CcSEcCtD
Fulvestrant—Cough—Donepezil—Alzheimer's disease	0.000637	0.00367	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000628	0.00362	CcSEcCtD
Fulvestrant—Back pain—Rivastigmine—Alzheimer's disease	0.000627	0.00361	CcSEcCtD
Fulvestrant—Myalgia—Donepezil—Alzheimer's disease	0.000621	0.00358	CcSEcCtD
Fulvestrant—Chest pain—Donepezil—Alzheimer's disease	0.000621	0.00358	CcSEcCtD
Fulvestrant—Arthralgia—Donepezil—Alzheimer's disease	0.000621	0.00358	CcSEcCtD
Fulvestrant—Anxiety—Donepezil—Alzheimer's disease	0.000619	0.00357	CcSEcCtD
Fulvestrant—Anaemia—Memantine—Alzheimer's disease	0.000612	0.00353	CcSEcCtD
Fulvestrant—Abdominal pain—Galantamine—Alzheimer's disease	0.000607	0.0035	CcSEcCtD
Fulvestrant—Body temperature increased—Galantamine—Alzheimer's disease	0.000607	0.0035	CcSEcCtD
Fulvestrant—ESR2—brain—Alzheimer's disease	0.000601	0.0293	CbGeAlD
Fulvestrant—Anaemia—Rivastigmine—Alzheimer's disease	0.000599	0.00345	CcSEcCtD
Fulvestrant—Vertigo—Memantine—Alzheimer's disease	0.000595	0.00343	CcSEcCtD
Fulvestrant—Leukopenia—Memantine—Alzheimer's disease	0.000593	0.00342	CcSEcCtD
Fulvestrant—Infection—Donepezil—Alzheimer's disease	0.000591	0.00341	CcSEcCtD
Fulvestrant—Nervous system disorder—Donepezil—Alzheimer's disease	0.000584	0.00337	CcSEcCtD
Fulvestrant—Vertigo—Rivastigmine—Alzheimer's disease	0.000582	0.00336	CcSEcCtD
Fulvestrant—Cough—Memantine—Alzheimer's disease	0.000578	0.00333	CcSEcCtD
Fulvestrant—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000576	0.00332	CcSEcCtD
Fulvestrant—Anorexia—Donepezil—Alzheimer's disease	0.000567	0.00327	CcSEcCtD
Fulvestrant—Hypersensitivity—Galantamine—Alzheimer's disease	0.000566	0.00326	CcSEcCtD
Fulvestrant—Cough—Rivastigmine—Alzheimer's disease	0.000565	0.00326	CcSEcCtD
Fulvestrant—Chest pain—Memantine—Alzheimer's disease	0.000564	0.00325	CcSEcCtD
Fulvestrant—Myalgia—Memantine—Alzheimer's disease	0.000564	0.00325	CcSEcCtD
Fulvestrant—Arthralgia—Memantine—Alzheimer's disease	0.000564	0.00325	CcSEcCtD
Fulvestrant—Anxiety—Memantine—Alzheimer's disease	0.000562	0.00324	CcSEcCtD
Fulvestrant—Arthralgia—Rivastigmine—Alzheimer's disease	0.000552	0.00318	CcSEcCtD
Fulvestrant—Myalgia—Rivastigmine—Alzheimer's disease	0.000552	0.00318	CcSEcCtD
Fulvestrant—Chest pain—Rivastigmine—Alzheimer's disease	0.000552	0.00318	CcSEcCtD
Fulvestrant—Asthenia—Galantamine—Alzheimer's disease	0.000551	0.00318	CcSEcCtD
Fulvestrant—Anxiety—Rivastigmine—Alzheimer's disease	0.00055	0.00317	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000548	0.00316	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000542	0.00313	CcSEcCtD
Fulvestrant—ESR1—nervous system—Alzheimer's disease	0.000539	0.0263	CbGeAlD
Fulvestrant—Insomnia—Donepezil—Alzheimer's disease	0.000538	0.0031	CcSEcCtD
Fulvestrant—Infection—Memantine—Alzheimer's disease	0.000537	0.0031	CcSEcCtD
Fulvestrant—Paraesthesia—Donepezil—Alzheimer's disease	0.000535	0.00308	CcSEcCtD
Fulvestrant—Dyspnoea—Donepezil—Alzheimer's disease	0.000531	0.00306	CcSEcCtD
Fulvestrant—Nervous system disorder—Memantine—Alzheimer's disease	0.00053	0.00306	CcSEcCtD
Fulvestrant—Diarrhoea—Galantamine—Alzheimer's disease	0.000526	0.00303	CcSEcCtD
Fulvestrant—Infection—Rivastigmine—Alzheimer's disease	0.000525	0.00303	CcSEcCtD
Fulvestrant—Skin disorder—Memantine—Alzheimer's disease	0.000525	0.00303	CcSEcCtD
Fulvestrant—Dyspepsia—Donepezil—Alzheimer's disease	0.000524	0.00302	CcSEcCtD
Fulvestrant—Hyperhidrosis—Memantine—Alzheimer's disease	0.000523	0.00301	CcSEcCtD
Fulvestrant—ESR1—central nervous system—Alzheimer's disease	0.000519	0.0253	CbGeAlD
Fulvestrant—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000519	0.00299	CcSEcCtD
Fulvestrant—Decreased appetite—Donepezil—Alzheimer's disease	0.000518	0.00298	CcSEcCtD
Fulvestrant—Anorexia—Memantine—Alzheimer's disease	0.000515	0.00297	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000514	0.00296	CcSEcCtD
Fulvestrant—Skin disorder—Rivastigmine—Alzheimer's disease	0.000514	0.00296	CcSEcCtD
Fulvestrant—Fatigue—Donepezil—Alzheimer's disease	0.000513	0.00296	CcSEcCtD
Fulvestrant—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000511	0.00295	CcSEcCtD
Fulvestrant—Pain—Donepezil—Alzheimer's disease	0.000509	0.00293	CcSEcCtD
Fulvestrant—Constipation—Donepezil—Alzheimer's disease	0.000509	0.00293	CcSEcCtD
Fulvestrant—Dizziness—Galantamine—Alzheimer's disease	0.000508	0.00293	CcSEcCtD
Fulvestrant—ESR1—cerebellum—Alzheimer's disease	0.000507	0.0247	CbGeAlD
Fulvestrant—Anorexia—Rivastigmine—Alzheimer's disease	0.000504	0.00291	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000492	0.00284	CcSEcCtD
Fulvestrant—Insomnia—Memantine—Alzheimer's disease	0.000489	0.00282	CcSEcCtD
Fulvestrant—Vomiting—Galantamine—Alzheimer's disease	0.000488	0.00282	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000487	0.00281	CcSEcCtD
Fulvestrant—Paraesthesia—Memantine—Alzheimer's disease	0.000485	0.0028	CcSEcCtD
Fulvestrant—Rash—Galantamine—Alzheimer's disease	0.000484	0.00279	CcSEcCtD
Fulvestrant—Dermatitis—Galantamine—Alzheimer's disease	0.000484	0.00279	CcSEcCtD
Fulvestrant—Dyspnoea—Memantine—Alzheimer's disease	0.000482	0.00278	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000482	0.00278	CcSEcCtD
Fulvestrant—Headache—Galantamine—Alzheimer's disease	0.000481	0.00277	CcSEcCtD
Fulvestrant—Insomnia—Rivastigmine—Alzheimer's disease	0.000478	0.00276	CcSEcCtD
Fulvestrant—Dyspepsia—Memantine—Alzheimer's disease	0.000476	0.00274	CcSEcCtD
Fulvestrant—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000475	0.00274	CcSEcCtD
Fulvestrant—Urticaria—Donepezil—Alzheimer's disease	0.000473	0.00273	CcSEcCtD
Fulvestrant—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000471	0.00272	CcSEcCtD
Fulvestrant—Abdominal pain—Donepezil—Alzheimer's disease	0.000471	0.00271	CcSEcCtD
Fulvestrant—Body temperature increased—Donepezil—Alzheimer's disease	0.000471	0.00271	CcSEcCtD
Fulvestrant—Decreased appetite—Memantine—Alzheimer's disease	0.00047	0.00271	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000467	0.00269	CcSEcCtD
Fulvestrant—Fatigue—Memantine—Alzheimer's disease	0.000466	0.00269	CcSEcCtD
Fulvestrant—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000465	0.00268	CcSEcCtD
Fulvestrant—Pain—Memantine—Alzheimer's disease	0.000462	0.00266	CcSEcCtD
Fulvestrant—Constipation—Memantine—Alzheimer's disease	0.000462	0.00266	CcSEcCtD
Fulvestrant—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00046	0.00265	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000457	0.00263	CcSEcCtD
Fulvestrant—Nausea—Galantamine—Alzheimer's disease	0.000456	0.00263	CcSEcCtD
Fulvestrant—Fatigue—Rivastigmine—Alzheimer's disease	0.000456	0.00263	CcSEcCtD
Fulvestrant—Pain—Rivastigmine—Alzheimer's disease	0.000452	0.00261	CcSEcCtD
Fulvestrant—Constipation—Rivastigmine—Alzheimer's disease	0.000452	0.00261	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000442	0.00255	CcSEcCtD
Fulvestrant—Hypersensitivity—Donepezil—Alzheimer's disease	0.000439	0.00253	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000432	0.00249	CcSEcCtD
Fulvestrant—Urticaria—Memantine—Alzheimer's disease	0.000429	0.00248	CcSEcCtD
Fulvestrant—Abdominal pain—Memantine—Alzheimer's disease	0.000427	0.00246	CcSEcCtD
Fulvestrant—Body temperature increased—Memantine—Alzheimer's disease	0.000427	0.00246	CcSEcCtD
Fulvestrant—Asthenia—Donepezil—Alzheimer's disease	0.000427	0.00246	CcSEcCtD
Fulvestrant—Pruritus—Donepezil—Alzheimer's disease	0.000421	0.00243	CcSEcCtD
Fulvestrant—Urticaria—Rivastigmine—Alzheimer's disease	0.00042	0.00242	CcSEcCtD
Fulvestrant—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000418	0.00241	CcSEcCtD
Fulvestrant—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000418	0.00241	CcSEcCtD
Fulvestrant—ESR1—brain—Alzheimer's disease	0.000412	0.0201	CbGeAlD
Fulvestrant—Diarrhoea—Donepezil—Alzheimer's disease	0.000407	0.00235	CcSEcCtD
Fulvestrant—Hypersensitivity—Memantine—Alzheimer's disease	0.000398	0.0023	CcSEcCtD
Fulvestrant—Dizziness—Donepezil—Alzheimer's disease	0.000394	0.00227	CcSEcCtD
Fulvestrant—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00039	0.00225	CcSEcCtD
Fulvestrant—Asthenia—Memantine—Alzheimer's disease	0.000388	0.00224	CcSEcCtD
Fulvestrant—Pruritus—Memantine—Alzheimer's disease	0.000382	0.0022	CcSEcCtD
Fulvestrant—Asthenia—Rivastigmine—Alzheimer's disease	0.000379	0.00219	CcSEcCtD
Fulvestrant—Vomiting—Donepezil—Alzheimer's disease	0.000379	0.00218	CcSEcCtD
Fulvestrant—Rash—Donepezil—Alzheimer's disease	0.000375	0.00216	CcSEcCtD
Fulvestrant—Dermatitis—Donepezil—Alzheimer's disease	0.000375	0.00216	CcSEcCtD
Fulvestrant—Pruritus—Rivastigmine—Alzheimer's disease	0.000374	0.00216	CcSEcCtD
Fulvestrant—Headache—Donepezil—Alzheimer's disease	0.000373	0.00215	CcSEcCtD
Fulvestrant—Diarrhoea—Memantine—Alzheimer's disease	0.00037	0.00213	CcSEcCtD
Fulvestrant—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000362	0.00209	CcSEcCtD
Fulvestrant—Dizziness—Memantine—Alzheimer's disease	0.000357	0.00206	CcSEcCtD
Fulvestrant—Nausea—Donepezil—Alzheimer's disease	0.000354	0.00204	CcSEcCtD
Fulvestrant—Dizziness—Rivastigmine—Alzheimer's disease	0.00035	0.00202	CcSEcCtD
Fulvestrant—Vomiting—Memantine—Alzheimer's disease	0.000344	0.00198	CcSEcCtD
Fulvestrant—Rash—Memantine—Alzheimer's disease	0.000341	0.00196	CcSEcCtD
Fulvestrant—Dermatitis—Memantine—Alzheimer's disease	0.000341	0.00196	CcSEcCtD
Fulvestrant—Headache—Memantine—Alzheimer's disease	0.000339	0.00195	CcSEcCtD
Fulvestrant—Vomiting—Rivastigmine—Alzheimer's disease	0.000336	0.00194	CcSEcCtD
Fulvestrant—Rash—Rivastigmine—Alzheimer's disease	0.000333	0.00192	CcSEcCtD
Fulvestrant—Dermatitis—Rivastigmine—Alzheimer's disease	0.000333	0.00192	CcSEcCtD
Fulvestrant—Headache—Rivastigmine—Alzheimer's disease	0.000331	0.00191	CcSEcCtD
Fulvestrant—Nausea—Memantine—Alzheimer's disease	0.000321	0.00185	CcSEcCtD
Fulvestrant—Nausea—Rivastigmine—Alzheimer's disease	0.000314	0.00181	CcSEcCtD
Fulvestrant—CYP3A4—nervous system—Alzheimer's disease	0.000301	0.0147	CbGeAlD
Fulvestrant—CYP3A4—central nervous system—Alzheimer's disease	0.000289	0.0141	CbGeAlD
Fulvestrant—EPHX2—Metabolism—ACHE—Alzheimer's disease	9.93e-05	0.000765	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.92e-05	0.000765	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—INPP5D—Alzheimer's disease	9.82e-05	0.000756	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MAOB—Alzheimer's disease	9.82e-05	0.000756	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	9.75e-05	0.000752	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—PPARG—Alzheimer's disease	9.68e-05	0.000746	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—Alzheimer's disease	9.67e-05	0.000745	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—TP53—Alzheimer's disease	9.65e-05	0.000744	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GAPDH—Alzheimer's disease	9.45e-05	0.000728	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.34e-05	0.00072	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ENO1—Alzheimer's disease	9.3e-05	0.000717	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS1—Alzheimer's disease	9.3e-05	0.000717	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.26e-05	0.000713	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	9.14e-05	0.000704	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—A2M—Alzheimer's disease	9.12e-05	0.000703	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP2D6—Alzheimer's disease	9.12e-05	0.000703	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	9.05e-05	0.000698	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	9.03e-05	0.000696	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	8.95e-05	0.000689	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—MAPK8—Alzheimer's disease	8.86e-05	0.000683	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PHF1—Alzheimer's disease	8.65e-05	0.000667	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—BCHE—Alzheimer's disease	8.65e-05	0.000666	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	8.57e-05	0.00066	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	8.5e-05	0.000655	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.47e-05	0.000652	CbGpPWpGaD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—AKT1—Alzheimer's disease	8.47e-05	0.000652	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	8.4e-05	0.000647	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	8.32e-05	0.000641	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PLCB1—Alzheimer's disease	8.16e-05	0.000629	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.14e-05	0.000627	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.14e-05	0.000627	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—TGFB1—Alzheimer's disease	8.12e-05	0.000626	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	8.11e-05	0.000625	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.01e-05	0.000617	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	7.94e-05	0.000612	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ACHE—Alzheimer's disease	7.94e-05	0.000612	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ABCA1—Alzheimer's disease	7.91e-05	0.00061	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INPP5D—Alzheimer's disease	7.85e-05	0.000605	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—ESR1—Alzheimer's disease	7.75e-05	0.000597	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	7.74e-05	0.000597	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	7.68e-05	0.000592	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—EIF2S1—Alzheimer's disease	7.64e-05	0.000589	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	7.49e-05	0.000577	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CHAT—Alzheimer's disease	7.48e-05	0.000576	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TPI1—Alzheimer's disease	7.48e-05	0.000576	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—GSK3B—Alzheimer's disease	7.46e-05	0.000575	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	7.44e-05	0.000573	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ENO1—Alzheimer's disease	7.44e-05	0.000573	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS1—Alzheimer's disease	7.44e-05	0.000573	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CREB1—Alzheimer's disease	7.4e-05	0.00057	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP2D6—Alzheimer's disease	7.29e-05	0.000562	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MAOB—Alzheimer's disease	7.17e-05	0.000553	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—PPARG—Alzheimer's disease	7.07e-05	0.000545	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	7.05e-05	0.000543	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—BCHE—Alzheimer's disease	6.92e-05	0.000533	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GAPDH—Alzheimer's disease	6.9e-05	0.000532	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—Alzheimer's disease	6.86e-05	0.000528	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.83e-05	0.000526	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARGC1A—Alzheimer's disease	6.82e-05	0.000525	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HMOX1—Alzheimer's disease	6.79e-05	0.000523	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.76e-05	0.000521	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—ESR1—Alzheimer's disease	6.75e-05	0.00052	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—A2M—Alzheimer's disease	6.67e-05	0.000514	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—EIF2S1—Alzheimer's disease	6.66e-05	0.000513	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	6.59e-05	0.000507	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—Alzheimer's disease	6.54e-05	0.000504	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	6.53e-05	0.000503	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PLCB1—Alzheimer's disease	6.53e-05	0.000503	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.4e-05	0.000493	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ABCA1—Alzheimer's disease	6.32e-05	0.000487	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	6.25e-05	0.000481	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	6.25e-05	0.000481	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—LPL—Alzheimer's disease	6.21e-05	0.000478	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	6.17e-05	0.000475	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—Alzheimer's disease	6.16e-05	0.000475	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6e-05	0.000463	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—Alzheimer's disease	5.98e-05	0.000461	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.95e-05	0.000458	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.93e-05	0.000457	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.81e-05	0.000447	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ACHE—Alzheimer's disease	5.8e-05	0.000447	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INPP5D—Alzheimer's disease	5.73e-05	0.000442	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—AKT1—Alzheimer's disease	5.65e-05	0.000435	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTHFR—Alzheimer's disease	5.59e-05	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TFAM—Alzheimer's disease	5.57e-05	0.00043	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	5.51e-05	0.000425	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARGC1A—Alzheimer's disease	5.45e-05	0.00042	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS1—Alzheimer's disease	5.44e-05	0.000419	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ENO1—Alzheimer's disease	5.44e-05	0.000419	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—Alzheimer's disease	5.43e-05	0.000418	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2D6—Alzheimer's disease	5.33e-05	0.000411	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CALM1—Alzheimer's disease	5.22e-05	0.000402	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—AKT1—Alzheimer's disease	5.22e-05	0.000402	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOE—Alzheimer's disease	5.2e-05	0.000401	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	5.18e-05	0.000399	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CAV1—Alzheimer's disease	5.16e-05	0.000397	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—ESR1—Alzheimer's disease	5.11e-05	0.000394	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—BCHE—Alzheimer's disease	5.05e-05	0.000389	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—LPL—Alzheimer's disease	4.96e-05	0.000382	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NOTCH1—Alzheimer's disease	4.94e-05	0.00038	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.92e-05	0.000379	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	4.91e-05	0.000378	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.9e-05	0.000378	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PLCB1—Alzheimer's disease	4.77e-05	0.000367	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.68e-05	0.00036	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.68e-05	0.00036	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—Alzheimer's disease	4.66e-05	0.000359	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ABCA1—Alzheimer's disease	4.62e-05	0.000356	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TTR—Alzheimer's disease	4.59e-05	0.000353	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.57e-05	0.000352	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.55e-05	0.000351	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—Alzheimer's disease	4.53e-05	0.000349	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTHFR—Alzheimer's disease	4.47e-05	0.000344	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.46e-05	0.000344	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—INS—Alzheimer's disease	4.45e-05	0.000343	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.4e-05	0.000339	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.2e-05	0.000323	CbGpPWpGaD
Fulvestrant—Estradiol—ESR1—Alzheimer's disease	4.18e-05	1	CrCbGaD
Fulvestrant—ESRRA—Metabolism—CALM1—Alzheimer's disease	4.17e-05	0.000322	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOE—Alzheimer's disease	4.16e-05	0.000321	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAV1—Alzheimer's disease	4.12e-05	0.000318	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PYY—Alzheimer's disease	4.01e-05	0.000309	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARGC1A—Alzheimer's disease	3.98e-05	0.000307	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—Alzheimer's disease	3.97e-05	0.000306	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—Alzheimer's disease	3.9e-05	0.0003	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.87e-05	0.000299	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ESR1—Alzheimer's disease	3.73e-05	0.000288	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LPL—Alzheimer's disease	3.63e-05	0.000279	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—Alzheimer's disease	3.62e-05	0.000279	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH1—Alzheimer's disease	3.61e-05	0.000278	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—Alzheimer's disease	3.57e-05	0.000275	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.56e-05	0.000274	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INS—Alzheimer's disease	3.55e-05	0.000274	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.53e-05	0.000272	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	3.48e-05	0.000268	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—Alzheimer's disease	3.41e-05	0.000262	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	3.36e-05	0.000259	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	3.35e-05	0.000258	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.32e-05	0.000256	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.29e-05	0.000254	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—Alzheimer's disease	3.27e-05	0.000252	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—ESR1—Alzheimer's disease	3.25e-05	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	3.22e-05	0.000248	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH1—Alzheimer's disease	3.14e-05	0.000242	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—Alzheimer's disease	3.12e-05	0.00024	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.11e-05	0.000239	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CALM1—Alzheimer's disease	3.05e-05	0.000235	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—Alzheimer's disease	3.04e-05	0.000234	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	3.04e-05	0.000234	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAV1—Alzheimer's disease	3.01e-05	0.000232	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	3e-05	0.000231	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.98e-05	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	2.97e-05	0.000229	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—Alzheimer's disease	2.97e-05	0.000228	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.93e-05	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	2.92e-05	0.000225	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—Alzheimer's disease	2.85e-05	0.00022	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	2.84e-05	0.000219	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAL—Alzheimer's disease	2.78e-05	0.000214	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	2.78e-05	0.000214	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—Alzheimer's disease	2.65e-05	0.000204	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—Alzheimer's disease	2.6e-05	0.0002	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.58e-05	0.000199	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.47e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—A2M—Alzheimer's disease	2.45e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	2.37e-05	0.000183	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—Alzheimer's disease	2.28e-05	0.000175	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.19e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPY—Alzheimer's disease	2.18e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	2.17e-05	0.000167	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CRH—Alzheimer's disease	2.11e-05	0.000162	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—Alzheimer's disease	2.08e-05	0.000161	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.06e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPS—Alzheimer's disease	2e-05	0.000154	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.99e-05	0.000153	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	1.96e-05	0.000151	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.95e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SST—Alzheimer's disease	1.9e-05	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	1.9e-05	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	1.9e-05	0.000147	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	1.89e-05	0.000145	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.86e-05	0.000144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APP—Alzheimer's disease	1.86e-05	0.000143	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—Alzheimer's disease	1.84e-05	0.000142	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—Alzheimer's disease	1.79e-05	0.000138	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.79e-05	0.000138	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	1.75e-05	0.000135	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.72e-05	0.000133	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.66e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	1.63e-05	0.000126	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	1.6e-05	0.000123	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	1.58e-05	0.000122	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—S100B—Alzheimer's disease	1.51e-05	0.000116	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—Alzheimer's disease	1.5e-05	0.000115	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	1.44e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—Alzheimer's disease	1.43e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	1.39e-05	0.000107	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—Alzheimer's disease	1.35e-05	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LPL—Alzheimer's disease	1.33e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	1.29e-05	9.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGF—Alzheimer's disease	1.26e-05	9.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	1.23e-05	9.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	1.2e-05	9.25e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—Alzheimer's disease	1.17e-05	9.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	1.12e-05	8.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—Alzheimer's disease	1.12e-05	8.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—Alzheimer's disease	1.12e-05	8.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	1.11e-05	8.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.07e-05	8.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.07e-05	8.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—Alzheimer's disease	1.05e-05	8.11e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—Alzheimer's disease	1.05e-05	8.07e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.03e-05	7.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.03e-05	7.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	9.88e-06	7.61e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	9.67e-06	7.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	9.59e-06	7.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—A2M—Alzheimer's disease	9.54e-06	7.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—Alzheimer's disease	9.54e-06	7.35e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	9.38e-06	7.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	9.22e-06	7.11e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	8.36e-06	6.44e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.3e-06	6.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.21e-06	6.32e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.78e-06	6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.78e-06	6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.63e-06	5.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.23e-06	5.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	7.1e-06	5.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.83e-06	5.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.62e-06	5.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	6.53e-06	5.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	6.02e-06	4.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—Alzheimer's disease	5.91e-06	4.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.7e-06	4.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.68e-06	4.37e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	5.53e-06	4.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.19e-06	4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.67e-06	3.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—Alzheimer's disease	4.55e-06	3.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.37e-06	3.36e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.35e-06	3.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.31e-06	3.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—Alzheimer's disease	4.17e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	3.84e-06	2.96e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.79e-06	2.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—Alzheimer's disease	3.72e-06	2.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.26e-06	2.51e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.98e-06	2.3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.5e-06	1.15e-05	CbGpPWpGaD
